SCHEMBL2865396

SCHEMBL2865396

O=C(O[N+](=O)[O-])c1ccccc1C(=O)O[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.43
ALDH1A1 P00352 5/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CTSD P07339 1/20 0.40
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 1/20 0.39
CYP3A4 P08684 1/20 0.39
PTGS2 P35354 2/20 0.39
KCNMA1 Q12791 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027098 0.92 ALDH1A1 (0.54) TSHRALDH1A1HPGDKDM4EALOX15
Zinc Ion SCHEMBL28381506 0.90 ALDH1A1 (0.47) TSHRALDH1A1LMNAHPGDKDM4E
SCHEMBL28140248 0.90 ALDH1A1 (0.52) TSHRALDH1A1HPGDKDM4EALOX15
SCHEMBL28254424 0.90 TSHR (0.57) TSHRALDH1A1LMNAHPGDKDM4E
SCHEMBL78138 0.86 ALDH1A1 (0.56) TSHRALDH1A1HPGDKDM4ECTSD
SCHEMBL11764313 0.86 NPC1 (0.50) TSHRALDH1A1LMNAHPGDHSD17B10
SCHEMBL6171195 0.86 PTPN2 (0.46) TSHRALDH1A1LMNAHPGDKDM4E
SCHEMBL1133328 0.86 ALDH1A1 (0.58) ALDH1A1KDM4ECTSDNPC1CYP3A4
SCHEMBL4099229 0.85 ALDH1A1 (0.56) ALDH1A1KDM4ECTSDNPC1CYP3A4
SCHEMBL4103993 0.85 ALDH1A1 (0.56) ALDH1A1KDM4ECTSDNPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109180048-B Nano precursor medium transmission inhibitor and preparation method thereof 江苏苏博特新材料股份有限公司 2021-12-17 CN claimed
CN-109180493-B Method for preparing 3-nitrophthalic acid and 4-nitrophthalic acid from mixed nitrophthalic acid 河北鸿旭翔药业有限公司 2021-09-03 CN disclosed
CN-110133973-A Two-component developing agent used for static latent image developing 柯尼卡美能达株式会社 2019-08-16 CN disclosed
CN-103852987-B Transparent toner, developer, toner cartridge, developer box, handle box, image forming apparatus and image forming method 富士施乐株式会社 2019-03-19 CN disclosed
CN-109233141-A A kind of manufacturing process of high shielding charcoal mould plate 浙江农林大学 2019-01-18 CN disclosed
EP-3074383-B1 IMPROVED PROCESS FOR THE PREPARATION OF POMALIDOMIDE AND ITS PURIFICATION MYLAN LABORATORIES LTD (IN) 2018-10-10 EP disclosed
US-20170260157-A1 PROCESS FOR PREPARATION AND PURIFICATION OF POMALIDOMIDE APICORE US LLC (US) 2017-09-14 US disclosed
CN-104114619-B Fiber-reinforced resin composite body, and reinforced matrix resin for fiber-reinforced resin DIC株式会社 2017-04-12 CN disclosed
US-20160362391-A1 Improved Process for the Preparation of Pomalidomide and its Purification Mylan Laboratories Ltd. (IN) 2016-12-15 US disclosed
EP-3074383-A1 IMPROVED PROCESS FOR THE PREPARATION OF POMALIDOMIDE AND ITS PURIFICATION Mylan Laboratories Ltd. (IN) 2016-10-05 EP disclosed
US-7018456-B2 Phthalocyanine compound, water-base ink composition and colored material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20050120910-A1 Phthalocyanine compound, water-base ink composition and colored material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-06-09 US disclosed
US-6690573-B2 Aluminum electrolytic capacitor and method for producing the same MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2004-02-10 US disclosed
US-20030169559-A1 Aluminum electrolytic capacitor and method for producing the same MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2003-09-11 US disclosed
CN-1430233-A Aluminium electrolytic capacitor and its making method MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2003-07-16 CN disclosed
US-20030073850-A1 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use ABBOTT LABORATORIES 2003-04-17 US disclosed
EP-1259491-A1 4-IMIDAZOLE DERIVATIVES OF BENZYL AND RESTRICTED BENZYL SULFONAMIDES, SULFAMIDES, UREAS, CARBAMATES AND AMIDES AND THEIR USE AS ALPHA-1A AGONISTS Abbott Laboratories (US) 2002-11-27 EP disclosed
US-6427599-B1 AUTOMOBILE AIR BAGS; DECOY FLARES BAE SYSTEMS INTEGRATED DEFENSE SOLUTIONS INC. 2002-08-06 US disclosed
WO-2001060802-A1 4-IMIDAZOLE DERIVATIVES OF BENZYL AND RESTRICTED BENZYL SULFONAMIDES, SULFAMIDES, UREAS, CARBAMATES, AND AMIDES AND THEIR USE AS ALPHA-1A AGONISTS ABBOTT LABORATORIES (US) 2001-08-23 WO disclosed
CN-1297236-A Solid electrolytic capacitor and its mfg. method MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2001-05-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073850-A1 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use ADRA1D, ADRB1, ADRA1A TSHR 155/4885ALDH1A1 263/4885LMNA 3579/4885
US-20160362391-A1 Improved Process for the Preparation of Pomalidomide and its Purification HEXD, MGAM, RPN1 TSHR 1336/4885ALDH1A1 3772/4885LMNA 3204/4885
US-20170260157-A1 PROCESS FOR PREPARATION AND PURIFICATION OF POMALIDOMIDE QDPR, NQO2, GDI1 TSHR 2222/4885ALDH1A1 609/4885LMNA 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.